(RS)-4-Carboxyphenylglycine
CAS No. 7292-81-1
(RS)-4-Carboxyphenylglycine( —— )
Catalog No. M33915 CAS No. 7292-81-1
(RS)-4-Carboxyphenylglycine is a racemic mixture. (S)-4-Carboxyphenylglycine is a selective mGlu1α receptor antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 31 | In Stock |
|
| 10MG | 48 | In Stock |
|
| 25MG | 79 | In Stock |
|
| 50MG | 116 | In Stock |
|
| 100MG | 169 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 402 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(RS)-4-Carboxyphenylglycine
-
NoteResearch use only, not for human use.
-
Brief Description(RS)-4-Carboxyphenylglycine is a racemic mixture. (S)-4-Carboxyphenylglycine is a selective mGlu1α receptor antagonist.
-
Description(RS)-4-Carboxyphenylglycine is a racemic mixture. (S)-4-Carboxyphenylglycine is a selective mGlu1α receptor antagonist.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number7292-81-1
-
Formula Weight195.17
-
Molecular FormulaC9H9NO4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(C(O)=O)(N)C1=CC=C(C(O)=O)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
α-Conotoxin IMI
α-Conotoxin Im-I is a selective α7/α9 nAChR antagonist, blocking α7 nicotinic receptors with the highest apparent affinity, while having an 8-fold lower affinity for homomeric α9 nicotinic receptors. α-Conotoxin Im-I is toxic and induces seizures in rodents. α-Conotoxin Im-I is a tool for studying neuronal nAChR.
-
Filorexant
Filorexant is an orally bioavailable effective and selective reversible antagonist of OX1 and OX2 receptor with (Ki <3 nM).
-
8-Hydroxyguanosine
8-hydroxyguanosine (8-OHG) is a marker for measuring the rate of oxidative damage to nucleic acids and lipids.The concentration of 8-OHG in CSF in Parkinson's disease (PD) patients is approximately three-fold that in controls. The concentration of 8-OHG in CSF decreased significantly with the duration of disease. However, the concentration of 8-OHG in serum was not significantly altered in PD patients compared to that in controls.
Cart
sales@molnova.com